Anti-miRs Competitively Inhibit microRNAs in Argonaute Complexes

Open Access

Peer-reviewed

Research Article

Daniel J. Hogan,

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
Thomas M. Vincent,

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
Sarah Fish,

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
Eric G. Marcusson,

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
Balkrishen Bhat,

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
B. Nelson Chau ,

* E-mail: nchau@regulusrx.com (BNC); dzisoulis@regulusrx.com (DGZ)

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯
Dimitrios G. Zisoulis

* E-mail: nchau@regulusrx.com (BNC); dzisoulis@regulusrx.com (DGZ)

Affiliation Regulus Therapeutics, San Diego, California, United States of America
⨯

Reader Comments (0)

MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Messenger RNA
Is the Subject Area "Messenger RNA" applicable to this article?

Thanks for your feedback.
Drug marketing
Is the Subject Area "Drug marketing" applicable to this article?

Thanks for your feedback.
Oligonucleotides
Is the Subject Area "Oligonucleotides" applicable to this article?

Thanks for your feedback.
Luminescence
Is the Subject Area "Luminescence" applicable to this article?

Thanks for your feedback.
Complement system
Is the Subject Area "Complement system" applicable to this article?

Thanks for your feedback.
RNA extraction
Is the Subject Area "RNA extraction" applicable to this article?

Thanks for your feedback.
Binding analysis
Is the Subject Area "Binding analysis" applicable to this article?

Thanks for your feedback.